Ozempic is changing people's skin, say plastic surgeons
Ozempic users are experiencing skin quality changes, including loss of elasticity and thinner SMAS layers, leading to accelerated aging signs. Surgeons are adapting techniques, while Novo Nordisk monitors safety.
Read original articleOzempic, a GLP-1 medication primarily used for weight loss, is reportedly affecting the skin quality of its users, according to plastic surgeons. Approximately 15.5 million U.S. adults have taken Ozempic, and many are seeking plastic surgery to address skin changes resulting from rapid weight loss. Surgeons have observed that the skin of Ozempic users often resembles that of an "old, overused rubber band," indicating a loss of elasticity and structural integrity. The SMAS layer, crucial for facial support, appears thinner in these patients, which could compromise surgical outcomes. Surgeons are also noting accelerated aging signs, such as increased fine lines and sagging skin, not only on the face but also on other body parts. The rapid weight loss associated with GLP-1s may prevent the skin from retracting properly, leading to sagging. Some experts suggest that GLP-1s may inhibit the function of adipose-derived stem cells, which are essential for skin health. As a result, patients are increasingly requesting non-surgical treatments to combat these effects. The pharmaceutical company Novo Nordisk has acknowledged the need for ongoing safety monitoring but has not confirmed any specific studies on the impact of semaglutide on skin quality.
- Ozempic users are experiencing notable changes in skin quality, including loss of elasticity.
- The SMAS layer in patients on GLP-1s is reportedly thinner, affecting surgical outcomes.
- Accelerated facial aging signs are common among those who have lost weight rapidly on GLP-1s.
- Surgeons are adapting their techniques to address the unique needs of GLP-1 patients.
- Novo Nordisk emphasizes patient safety and ongoing monitoring of their medications.
Related
'Skinny jabs': weight-loss drugs set for new boom as generic versions emerge
Medicines like Wegovy and Saxenda, known as "skinny jabs," are gaining popularity for weight loss. Generic versions, like Teva's generic Victoza, are expected to increase accessibility and affordability, benefiting a broader population. Novo Nordisk invests $4 billion to meet rising demand.
GLP-1 Drugs Like Wegovy, Ozempic Potentially Linked to Blinding Disease
A study suggests a potential link between GLP-1 drugs like semaglutide and a rare blinding disease called NAION in patients with diabetes or obesity. Further research is needed to clarify this association.
Popular Prescription Weight Loss Drugs Linked to Uncommon Blinding Condition
A study links semaglutide use to increased risk of NAION in diabetes and weight loss patients. Discussion on risks is crucial despite lack of causality, urging further research for clarity.
Not Everyone Loses Weight on Ozempic
Some patients may not achieve significant weight loss with GLP-1 drugs like Ozempic and Wegovy, despite promising trial results. Factors like genetics and adherence influence responses. Newer drugs like tirzepatide aim to improve effectiveness.
Weight-loss drugs are causing people to spend less at the grocery store: study
A study by Grocery Doppio shows weight-loss medications like Ozempic and Wegovy lead users to spend less on groceries, buy healthier foods, and significantly reduce purchases of snacks and sugary items.
- Some commenters question the potential conflict of interest for plastic surgeons who may benefit financially from procedures like liposuction.
- There are suggestions for combining Ozempic with skincare treatments, such as Retinol, to mitigate skin quality issues.
- Several users express skepticism about the long-term effects of rapid weight loss on skin health, with some attributing sagging skin to malnutrition or muscle loss.
- Concerns are raised about the overall health implications of prioritizing weight loss over skin quality.
- Some commenters note that rapid weight loss can lead to skin changes, but recovery may occur over time.
- it's just stretched skin
- people get on ozempic but are not eating nutritious diets, so now they are malnourished
1. If other weight loss methods also have significant impacts on the skin, it seems plausible that a shared mechanism could be the most parsimonious explanation. Therefore, if this effect exists, it might be due to weight loss itself rather than specifically due to Ozempic. The article cites a study supporting the fact that dramatic weight loss has negative impacts on skin health.
2. GLP-1 agonists modify appetite, which could lead people to consume less satiating foods (e.g., protein). This might negatively affect both lean muscle and skin health. There is data supporting collagen supplementation for skin health, as collagen likely raises serum amino acids. This would have the opposite effect on skin health compared to a lower intake of protein.
3. The observations made by plastic surgeons might be influenced by healthy user bias. Ozempic is an expensive medication, and insurance coverage is generally granted to those who are already quite unhealthy. To make a fair comparison, these patients should be compared to individuals with similar health characteristics.
It's also worth adopting an engineering mindset and considering the trade-offs involved. For someone who is extremely metabolically unhealthy, the benefits of weight loss might outweigh potential negative effects on the skin in terms of long-term health.
Right, because 15 years ago nobody else lost any weight. GLP-1s and roux-en-Y are literally the only two treatments shown in clinical studies that cause people to lose weight and keep it off indefinitely.
Maybe the skin is saggy because there’s nothing under it, maybe not? But at least they won’t have a stroke, heart attack, cancer or type 2.
Chemo is going to make you look much worse.
The new category of patient is “person who successfully lost weight and kept it off without gastric bypass.”
[edit] if you think I’m exaggerating there’s a great study from 2023 that tracked how many people lost more than 5% body weight in a given year.
Answer: 1 in 10, skewing mostly to people who had more to lose.
If you were morbidly obese your probability of achieving a healthy weight is 1 in 1667 in a year.
And if you manage to thread that needle your average weight regain over 5 years is 80%.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle...
So now you might get free weight loss without making any effort at all, but you'll also look older in the process?
I have to say, my father has been taking it, and I noticed that he does look older all of a sudden...and his weight loss also plateaued. I thought it was just my imagination, but maybe not.
Ultimately this article is kind of a FUD nothing-burger. People's skin behaves the same anytime there is rapid weight loss.
Nothing worse than losing weight but most of the weight loss was muscle mass.
Related
'Skinny jabs': weight-loss drugs set for new boom as generic versions emerge
Medicines like Wegovy and Saxenda, known as "skinny jabs," are gaining popularity for weight loss. Generic versions, like Teva's generic Victoza, are expected to increase accessibility and affordability, benefiting a broader population. Novo Nordisk invests $4 billion to meet rising demand.
GLP-1 Drugs Like Wegovy, Ozempic Potentially Linked to Blinding Disease
A study suggests a potential link between GLP-1 drugs like semaglutide and a rare blinding disease called NAION in patients with diabetes or obesity. Further research is needed to clarify this association.
Popular Prescription Weight Loss Drugs Linked to Uncommon Blinding Condition
A study links semaglutide use to increased risk of NAION in diabetes and weight loss patients. Discussion on risks is crucial despite lack of causality, urging further research for clarity.
Not Everyone Loses Weight on Ozempic
Some patients may not achieve significant weight loss with GLP-1 drugs like Ozempic and Wegovy, despite promising trial results. Factors like genetics and adherence influence responses. Newer drugs like tirzepatide aim to improve effectiveness.
Weight-loss drugs are causing people to spend less at the grocery store: study
A study by Grocery Doppio shows weight-loss medications like Ozempic and Wegovy lead users to spend less on groceries, buy healthier foods, and significantly reduce purchases of snacks and sugary items.